← All stocks

Perspective Therapeutics, Inc.

CATX Net buying
CIK 0000728387 #3362 in the set updated 17 Sep 2026
Bought (120 mo)
$59.60M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.62M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.62M
7 of 7 sales
Net
+$57.98M
+$57.98M against sales at will

By person

18 insiders · 152 transactions
0.2×

Johan (Thijs) Spoor holds only 0.2 times base salary in stock. $201.52K of shares against $680.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Johan (Thijs) Spoor last reported holding, valued at $3.15, the price Common Stock was last bought or sold at on the open market here, on 4 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Lantheus Alpha Therapy, LLC entity
10% owner
$57.41M (1)
$1.27M (5)
+$56.14M
11,273,364
9.88%
$35.48M
Williamson Robert F III
Director
$493.67K (25)
+$493.67K
118,846
0.1041%
$374.03K
Woods Lori A
Director
$417.30K (15)
+$417.30K
1,078,574
0.9449%
$3.39M
Lantheus Holdings, Inc. entity
10% owner
$357.18K (2)
−$357.18K
11,563,425
10.13%
$36.39M
−1.0%
Puhlmann Markus
Chief Medical Officer
$328.63K (4)
+$328.63K
1,375,425
1.20%
$4.33M
+175.1%
Spoor Johan M.
Chief Executive Officer
$307.70K (7)
+$307.70K
64,033
0.0561%
$201.52K
Hunt Jonathan Robert
Chief Accounting Officer
$234.94K (14)
+$234.94K
59,800
0.0524%
$188.20K
HENSON HEIDI
Director
$100.00K (1)
+$100.00K
25,975
0.0228%
$81.75K
Graham Juan
Chief Financial Officer
$74.95K (1)
+$74.95K
35,354
0.0310%
$111.27K
+1,649%
Krachon Michael
EVP of Sales & Marketing
$61.87K (17)
+$61.87K
133,844
0.1173%
$421.23K
Vitale Philip J
Director
$54.12K (21)
+$54.12K
240,000
0.2102%
$755.33K
+84.6%
LAVOY THOMAS C
CEO and Chairman of the Board
$44.56K (4)
+$44.56K
316,333
0.2771%
$995.56K
+120.4%
Hoffmann Alan
Director
$31.40K (3)
+$31.40K
64,230
0.0563%
$202.14K
Austin Mark John
VP Finance/Prin Fin&Acct Offic
$22.58K (11)
+$22.58K
84,030
0.0736%
$264.46K
Cavanagh William
Chief R&D Officer
$11.90K (3)
+$11.90K
27,692
0.0243%
$87.15K
McCormick Michael W
Director
$10.00K (1)
+$10.00K
41,230
0.0361%
$129.76K
+87.4%
Streeter Jennifer
COO & VP of HR
87,940
0.0770%
$276.76K
+469.6%
Cline Krista
Dir. of Operations, Secretary
22,933
0.0201%
$72.17K
+2,120%
Insider
Date
Role
Action
Shares
Price
Amount
Lantheus Alpha Therapy, LLC
4 Sep 2026
10% owner
Sell
167,149
$3.15
$526.05K
Lantheus Alpha Therapy, LLC
3 Sep 2026
10% owner
Sell
80,783
$3.11
$250.90K
Lantheus Alpha Therapy, LLC
2 Sep 2026
10% owner
Sell
42,129
$3.11
$131.22K
Lantheus Holdings, Inc.
1 Sep 2026
10% owner
Sell
35,769
$3.12
$111.57K
Lantheus Alpha Therapy, LLC
1 Sep 2026
10% owner
Sell
35,769
$3.12
$111.57K
Lantheus Holdings, Inc.
31 Aug 2026
10% owner
Sell
78,145
$3.14
$245.61K
Lantheus Alpha Therapy, LLC
31 Aug 2026
10% owner
Sell
78,145
$3.14
$245.61K

What was left out

Form 4 filings counted 168
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 1,018,748
History held since 21 Nov 2016